Compare PII & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PII | TMDX |
|---|---|---|
| Founded | 1954 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.4B |
| IPO Year | 1994 | 2019 |
| Metric | PII | TMDX |
|---|---|---|
| Price | $55.70 | $114.03 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $58.08 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 1.0M | 934.6K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.82% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 4.87 |
| Revenue | ★ $7,152,000,000.00 | $605,494,000.00 |
| Revenue This Year | $1.36 | $24.51 |
| Revenue Next Year | $4.40 | $18.72 |
| P/E Ratio | ★ N/A | $22.43 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $31.40 | $81.92 |
| 52 Week High | $75.25 | $156.00 |
| Indicator | PII | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 49.59 | 51.56 |
| Support Level | $55.71 | $109.43 |
| Resistance Level | $60.28 | $120.28 |
| Average True Range (ATR) | 2.17 | 5.39 |
| MACD | 0.57 | 1.89 |
| Stochastic Oscillator | 56.78 | 88.24 |
Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to pontoon and deck boat users. It is slated to divest its Indian motorcycle brand to Carolwood in the first quarter of 2026. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.